Annular Biotechnology LLC (“Annular”) is a biotechnology company formed for the purpose of contract manufacturing and early-stage development of monoclonal antibodies (mAbs). We have developed a novel approach which incorporates state-of-the-art technologies to facilitate high-throughput production of diverse mAb panels to biomedical targets, also known as our "Abitope Kits". Annular offers an improved methodology for selecting high-value hybridomas that produce mAb of greater market value. We can provide small firms and institutional researchers the ability to meet early criteria through a combination of development speed and mAb optimization. The net effect is improved discovery with the means to discard insignificant hybridomas and measurably improve otherwise lost clones resulting in panels of mAbs with varying specificities that can be exploited for numerous applications. The benefits of this technology can provide clients with a competitive edge translated to both diagnostic and therapeutic indications.